Health Insurance Reform and Rehabilitation Coverage

Published March 22, 2014

Health Insurance Reform and Rehabilitation Coverage — Presenter: Theresa Morgan, Legislative Director Powers, Pyles, Sutter, and Verville, PC recorded January 24, 2014.

FDA Approves Xolair(R) (omalizumab) for People with Chronic Idiopathic …
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Xolair(R) (omalizumab) for the treatment of chronic idiopathic urticaria (CIU), a form of chronic hives …
Read more on Wall Street Journal

Honoring Hometown Heroes
“With melanoma, there is no remission … because you never know when it's going to recur. When it comes …. They often refer patients to services and resources they can benefit from, like the American Cancer Society's “Look Good Feel Better,” “Reach …
Read more on The Star Democrat

Related Drug Rehabs In Md With No Insurance Information…